Brewin Dolphin LTD Liminal Bio Sciences Inc. Transaction History
Brewin Dolphin LTD
- $2.08 Billion
- Q2 2022
A detailed history of Brewin Dolphin LTD transactions in Liminal Bio Sciences Inc. stock. As of the latest transaction made, Brewin Dolphin LTD holds 234 shares of LMNL stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
234
Previous 234
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LMNL
# of Institutions
2Shares Held
234Call Options Held
0Put Options Held
0About Liminal BioSciences Inc.
- Ticker LMNL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,042,600
- Description
- Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...